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A B S T R A C T
The number of anthropogenic chemicals, manufactured, by-products, metabolites and abiotically formed
transformation products, counts to hundreds of thousands, at present. Thus, humans and wildlife are exposed to
complex mixtures, never one chemical at a time and rarely with only one dominating effect. Hence there is an
urgent need to develop strategies on how exposure to multiple hazardous chemicals and the combination of their
effects can be assessed. A workshop, “Advancing the Assessment of Chemical Mixtures and their Risks for Human
Health and the Environment” was organized in May 2018 together with Joint Research Center in Ispra, EU-
funded research projects and Commission Services and relevant EU agencies. This forum for researchers and
policy-makers was created to discuss and identify gaps in risk assessment and governance of chemical mixtures
as well as to discuss state of the art science and future research needs. Based on the presentations and discussions
at this workshop we want to bring forward the following Key Messages:
• We are at a turning point: multiple exposures and their combined effects require better management to
protect public health and the environment from hazardous chemical mixtures.• Regulatory initiatives should be launched to investigate the opportunities for all relevant regulatory fra-
meworks to include prospective mixture risk assessment and consider combined exposures to (real-life)
chemical mixtures to humans and wildlife, across sectors.• Precautionary approaches and intermediate measures (e.g. Mixture Assessment Factor) can already be ap-
plied, although, definitive mixture risk assessments cannot be routinely conducted due to significant
knowledge and data gaps.• A European strategy needs to be set, through stakeholder engagement, for the governance of combined
exposure to multiple chemicals and mixtures. The strategy would include research aimed at scientific ad-
vancement in mechanistic understanding and modelling techniques, as well as research to address regulatory
and policy needs. Without such a clear strategy, specific objectives and common priorities, research, and
policies to address mixtures will likely remain scattered and insufficient.
1. Introduction
Humans, wildlife and domestic animals are exposed to a large
number of different mixtures of anthropogenic chemicals via air, water,
food, consumer products, materials and goods. In addition, new che-
micals and new applications of existing chemicals are continuously
introduced to the market. Pharmaceuticals, drugs, tobacco and occu-
pational exposures add to the number and potential combinations of
chemical mixtures for humans. However, the current regulatory prac-
tice (Clahsen et al., 2019; Lebret, 2015) is largely based on considering
single chemical substances. The combined exposure to multiple che-
micals raises concerns about the effects on health and the environment,
as the failure to account for the effects of combined exposures could
lead to underestimation of risk (Kortenkamp and Faust, 2018).
Scientific progress has been achieved in recent years towards im-
proving our understanding of mixture effects and developing new
models to assess risks from combined exposures to multiple chemicals
(Bopp et al., 2019). Substantial progress in conceptual approaches to
address mixture risks has been achieved and useful methods for default
solutions are already available (More et al., 2019). Although evidence
of exposure and adverse effects are abundant, there is a significant need
to develop methods and search for advanced solutions on how we es-
tablish causality between exposure and effects. Also, given an almost
infinite number of real-life mixtures will make investigations of all of
them unworkable. Simplifications must be done to promote predictions
of exposure and effect assessments, which means that approaches for
more holistic mixture risk assessments (MRAs) remain a research
challenge.
Further, progress has been achieved in improving our under-
standing of the governance of uncertain, complex and ambiguous risk
problems and so-called “wicked problems” that span across various
sectors, jurisdictions and agencies (Allen, 2013). Mixture risk assess-
ment certainly qualifies as such a category of risk problems. Such
problems do not only require the input of natural and life science ex-
perts, but also input from political science, economics, law and from
broad stakeholder dialogues (Health Council of the Netherlands, 2008;
Petersen and van Asselt, 2008; Renn, 2008; Renn and Graham, 2005).
Many challenges and gaps are yet impeding the progress. Data gaps
on the various uses of the large number of chemicals on the market
remain, thus hindering more inclusive assessment based on real-life
exposures to coincidental mixtures (Bopp et al., 2018). It is inevitable
that more work is required to better understand and manage co-
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exposure to multiple chemicals, both with regards to intentional mix-
tures such as pesticide formulations and cosmetic products, and unin-
tentional mixtures in our indoor and outdoor environments, combined
with the pool of chemical exposures stemming from e.g. pharmaceu-
ticals, medical implants, recreational drugs, tobacco and other lifestyle
related exposures.
Against this background, a joint Workshop “Advancing the
Assessment of Chemical Mixtures and their Risks for Human Health and
the Environment” was held 29–30 May 2018 at Joint Research Centre
in Ispra, Italy, co-organised with several EU-funded research projects:
EDC-MixRisk, EuroMix, HBM4EU, SOLUTIONS, and EU-ToxRisk. The
purpose of this workshop was to create a joint forum for researchers
and policy-makers to discuss and identify gaps in risk assessment and
governance of chemical mixtures as well as to discuss state of the art
research and future research needs. The workshop brought together
around 60 experts, with representatives from the EU-funded research
projects, Commission services and EU agencies. Participants discussed
ways forward for advancing progress in the chemical mixture issue,
concerning both human health and the environment.
This paper was prepared in the context of the workshop. The
workshop plenary and group discussions form the basis of the present
document as well as the additional comments received via a survey
among participants after the workshop. The key issues and re-
commended actions in terms of policy, data and scientific challenges for
addressing chemical mixture risks and combined exposures are pre-
sented below.
To clarify the terminology used herein, the combined exposure to
multiple chemicals is defined as exposure to multiple chemicals via
single or multiple sources and/or pathways, whereas aggregate ex-
posure refers to exposure to the same chemical from multiple sources
and/or by multiple pathways according to the WHO/IPCS framework
(Meek et al., 2011).
The statements and proposals in this paper represent solely the
views of the workshop participants and not necessarily the views or
official policies of their organizations.
2. Current situation and future needs
2.1. Policy needs and options
2.1.1. Strengthen the legal basis for mixture risk management and
assessment by clear legal mandates
Our current regulatory systems are not designed for coping with co-
exposures to multiple chemicals of different application areas presently
regulated through different regulatory jurisdictions, e.g. biocides, cos-
metic ingredients and additives in material and products. The risk as-
sessment and management of chemicals focuses on single substances
while mixtures are only partly covered by the current regulatory fra-
meworks (Kienzler et al., 2014, 2016). The frameworks that only look
at compounds from a particular use or application class, e.g. pesticides
or biocides, are necessary, but seem insufficient in the light of in-
creasing evidence underlining the importance of considering co- ex-
posures against multiple chemicals beyond application class in order to
more adequately estimate risks they pose (Demeneix and Slama, 2019;
Evans et al., 2016).
Many workshop participants suggested that a more comprehensive
legal basis would help bridge not only regulatory gaps, but also con-
tribute significantly to method development and data provision. The
strengthening of the legal basis can be achieved e.g. by establishing
clear legal mandates for mixture risk assessment within all sectors of EU
chemicals, environmental and waste related legislation. Currently, the
EU pesticides legislation (Regulation (EC) No 1107/2009 and
Regulation (EC) 396/2005 on pesticide residues) and the biocides leg-
islation (Regulation (EU) No 528/2012) have specific provisions re-
garding the risk assessment of combined effects (Kienzler et al., 2014).
If legal provisions would be added to other chemical related
legislations, progress in this area would be possible. Furthermore, many
participants highlighted that based on the experiences of the US and the
EU regulatory systems (Rotter et al., 2018), it seems that significant
progress towards the effective inclusion of mixture risk assessments into
regulatory decision cannot be achieved without clear legal mandates
requiring competent authorities to develop and implement relevant
methodologies.
• “Review” of all pieces of EU chemical related legislation, regardless of
their origin, be it environmental, waste, occupation, food, diet, consumer
products or pharmaceuticals, to enable fuller, more inclusive mixture
impact assessments
A comprehensive review would enable a topical scanning of the
existing horizontal and sector-specific legislations and their provi-
sions and guidance on considering mixture risks in prospective
chemical risk assessment as well as in, ex-ante impact assessment.
Moreover, issues for cross-compliance between different sectors of
regulation, e.g. emission-based and quality-based standard setting
could be identified.
• Establish, in stakeholder dialogue, a “protection goal” for human health
with regards to chemical exposures which is embedded in regulations
The Water Framework Directive 2000/60/EC stipulates good che-
mical and ecological status for European water bodies. Good che-
mical status requires that concentration of pollutants do not exceed
environmental quality standards set at the EU level. A similar type of
protection goal could be set for good chemical status in the human
population. The goal could be limited to specific domains, e.g. non-
voluntary exposures such as environmental, occupational and
dietary exposures in the first instance. The status of the protection
goal could be assessed via human biomonitoring, which can be used
to identify exposure trends in the population or after a set period of
time to evaluate effectiveness of policy decisions and measures.
2.1.2. Strengthen coordination across regulatory bodies and sectors
Mistakes due to lack of coordination and communication, as pre-
viously made in history, should be avoided. For example, several che-
micals originally used as pesticides have been banned but continued to
be produced for other applications, such as flame retardants. Where
procedures for mixture risk assessments have already been drafted or
implemented under different pieces of EU law, they are fragmented and
not fully consistent in terminology and assessment rules. Different rules
and data requirements apply for the chemicals used for different pur-
poses and/or which are present in different environmental media. As
more frameworks, both horizontal (REACH) and sector-specific, should
include mixture risk assessment in legislation, it is important that in this
process, mixture risk management and risk assessment are approached
by the different sectors simultaneously in a coordinated manner. At
least, most relevant sources of exposure should be considered to begin
with a limited but relevant scope. These include environmental, occu-
pational and dietary exposures, as such involuntary exposures should
not impede or limit the elected use of e.g. pharmaceuticals.
It is suggested that mixture risk assessment could drive the har-
monisation of chemical and environmental legislation as the current
substance-by-substance assessment has its limitations. Harmonised
methodologies would ensure consistency, simplify interpretation and
help building confidence and support for integration into the regulatory
decision-making. To this end, novel cross-cutting initiatives and in-
stitutional arrangements were brought up in the discussions in order to
enable dialogue between scientific experts and policy makers. “Policy
labs” or “pilot platforms” could be initiated to find and introduce sui-
table procedures and processes for cross-sector coordination and har-
monization in various regulatory bodies. Although methodologies de-
veloped with data rich sectors of regulation, such as for medicinal
products or pesticides, certainly have the potential to drive develop-
ment of methods, there may be limitations to the application of these
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within other areas where less data is available.
• Case study to assess mixtures of substances covered by many sectors
It was proposed as a concrete step forward to initiate a case study
across regulatory areas to work together with the European
Commission and Agencies for a practical learning experience. A case
study would help concretizing the processes and drive the devel-
opment of cross-sector coordination forward. An evaluation of fun-
gicides was suggested, where similarly acting compounds are in-
cluded in different uses regulated under different legislative
frameworks. In addition, one regulatory agency could take the lead
in collecting the needs and stakeholder views on “cross-sectoral”
case study proposals in the future.
2.1.3. Introduce intermediate measures in line with precautionary
approaches, e.g. Application of mixture assessment factors (MAFs)
Intermediate measures that could be implemented on a relatively
short notice, include an additional assessment factor to account for
mixture effects. This would be a way to decrease the total burden of
exposure to chemical mixtures. It is evident that there is no single way
to address all mixture exposure and toxicity issues in one simple ap-
proach; For empirical assessment e.g., the number of potential mixtures
to test would be vast and such testing would not be feasible. Similarly,
modelling based on simplistic assumptions would raise concerns of too
many uncertain assumptions, so better ways of addressing both the
scientific, regulatory as well as societal needs are necessary. Given the
complexity of the problem, considerable uncertainties will remain for
the coming decades. Thus, decisions about acceptable mixture ex-
posures need to be made with some uncertainty, but taking benefit from
stepwise translation of science.
Making better use of existing options that are included already in
the current legislative frameworks, such as regulating substances as
groups under REACH and making use of restrictions could be empha-
sized more when there is a concern of significant health or environ-
mental impacts. The restriction proposal on the four phthalates, DEHP,
BBP, DBP, and DIBP,1 was made on this basis (EC, 2018a).
An important question raised at the workshop was how to avoid a
dilution of responsibilities: Even if every actor is responsible for just a
small contribution to an overall intolerable exposure level, the question
is how to get the overall exposure levels limited to “safe(r)” or accep-
table levels. Some workshop participants were in favour of more rapid
operationalization of intermediate measures as a way to decrease the
total burden of involuntary exposure to chemical mixtures. Where the
available evidence provides reasons for concern but a conclusive mix-
ture risk assessment cannot be reached due to significant knowledge
and data gaps and when potential serious and irreversible impacts are
considered possible, intermediate measures, such as a mixture assess-
ment factor (MAF), could be used to implement precautionary ap-
proaches.
• Application of mixture assessment factor (MAF)
One concrete step forward could be the application of an additional
assessment factor to account for possible combined exposures and
effects. It has been proposed as a simple fixed factor for lower tier
assessments to take account of mixture exposure in single substance
risk assessment. The application of MAFs would furthermore in-
crease the safety of the assessment of individual compounds. New
research should develop realistic models of the relative contribu-
tions made by subgroups of chemicals to the total exposure, as this
may help to further develop the MAF methodology. Some models
are already available for informing about a possible range of esti-
mating MAF, e.g. the acceptable concentration range models. These
new statistical models deliver “guideline values” for risk based on
epidemiological data to inform risk assessment of mixtures and
provide estimates of acceptable exposures (Gennings et al., 2018).
2.1.4. Integrate component-based and whole mixture testing approaches in
common tiered frameworks for human and environmental mixture risk
assessments
Existing proposals for tiered regulatory approaches to mixture risk
assessment largely focus on component-based approaches (CBAs).
These are scientifically reasonable but when translating them into
regulation they are often limited in application, missing data on mix-
ture components. Also, they may underestimate, or potentially over-
estimate, mixture risks that result from more/less than additive (sy-
nergistic/antagonistic) interactions. Where appropriate,
complementary use of CBA and whole mixture testing approaches
should be considered. This concept is currently under discussion at an
advanced stage in the context of EU water-related legislation. In the
Marine Strategy Framework Directive (MSFD, Directive 2008/56/EC),
effect-based methods are included as supplementary descriptors to as-
sess good environmental status on a voluntary basis. In environmental
monitoring, comprehensive mixture exposure assessment is often lim-
ited by chemical analytic methodology. Here, joint application of effect-
based methods and chemical analytics can help identify unresolved
effects and compounds. Techniques and case studies for the proposed
use of effect-based monitoring and related effect-based trigger values
have been provided (Escher et al. 2018; Neale et al. 2017), as well as a
concept of reference material mixtures based on main chemical drivers
of the priority substances.
• Complementing target chemical monitoring with effect-based methods
Strategies to complement chemical analytical data with effect de-
tection have been proposed. They differentiate suggestions with
regard to specific objectives, namely to identify relevant con-
taminants for complex exposure situations, to assess the impact of
contamination in aquatic ecosystems, and to quantify cause-effect-
relationships (Altenburger et al., 2019). For these different objec-
tives they specify complementary applications of bioanalytical and
chemical methods. Importantly, an array of effect-based methods is
to be collated, e.g. for long-term effects of concern, such as endo-
crine activity that reflect the monitoring goal.
2.2. Key enablers for connecting the dots: systematic data and tools
2.2.1. Complementary use of monitoring data and modelled exposure
Monitoring data can help identifying realistic co-exposure patterns
if several chemicals are analysed e.g. in the same environmental or
human samples. The use of Human Biomonitoring (HBM) data to
identify realistic co-exposures and to help assess mixture related risks is
gaining momentum. HBM data can account for combined exposure to
multiple chemicals as well as aggregate exposure from different sources
and via different routes, integrating, over time periods, bioaccumu-
lating compounds. It was discussed that a complementation with
modelling approach is warranted, e.g. predicting exposures based on
chemical use types and volumes. Monitoring data can then be used to
validate or calibrate such models. More generally, a full-scale com-
puter-based strategy could be included in the planning phase of the
initiative to increase interactions and exchanges between the con-
tinuous flow of big data from biomonitoring and exposure model out-
comes. Such interactions also aim at improving exposure models.
Practically, the development of the predictive models, which will rely
on new data, can benefit from artificial intelligence techniques that use
sophisticated algorithms. For example, machine learning techniques
such as natural language processing, deep learning, random forest and
Bayesian classifiers, to name a few, give the computer the ability to
learn from data (here biomonitoring data) in order to make predictions.
Such methods that have shown excellent performance in many fields,
1 Bis(2-ethylhexyl) phthalate (DEHP), Benzyl butyl phthalate (BBP), Dibutyl
phthalate (DBP) and Diisobutyl phthalate (DIBP).
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are fast and cost effective and should be helpful in many respects: (i)
developing an integrated framework for cumulative and aggregated
exposure, and improved predictive tools for internal doses based on
exposure pathways; (ii) using physiologically-based toxicokinetic
(PBTK) models to reconstruct exposures based on available information
(reverse dosimetry); (iii) filling gaps in knowledge concerning en-
vironmental or human biomonitoring through adequate modelling; (iv)
metabolic and kinetic interactions among mixture components; (v)
identifying target tissue levels of contaminants and mixtures and
therefore predicting the type of mixture present in target tissues; (vi)
using large scale human biomonitoring data to identify co-occurring
substances and mixture patterns in humans; this will also require spe-
cific tools based on combined data mining and statistical approaches to
extract relevant features; (vii) based on available adverse outcome
pathways (AOPs) and AOP networks, link relevant mixtures to adverse
outcomes and predict toxicodynamic interactions; this could be done
through innovative text mining and scoring tools combined to systems
biology and using large scale data sets (omics).
• Additional and regular collection of human biomonitoring data
Substitution of regulated or banned substances by often less well
investigated “new” substances, shifts in the market, alterations in
consumer habits, extended use of imported products from outside
the EU and the introduction of new regulation require a continuous
and regularly repeated screening of body burdens to elucidate real-
world exposures and assess the major drivers in mixtures in people
living in Europe, presently and at given future time points.
2.2.2. Adequate and good-quality exposure and hazard data are
prerequisites for MRA
Overall, the data availability and quality need to be improved.
Predictive mixture assessment depends on adequate exposure and ha-
zard data. Hazard and exposure data for mixture toxicity assessment are
often lacking, scattered across disciplinary databases, or only cover a
comparatively small number of chemicals, e.g. compounds considered
relevant from a regulatory single-substance perspective or the “usual
suspects” in academic (eco)toxicology and epidemiology.
• Coordination and data sharing within research community
Many participants agreed that coordination efforts within the re-
search community are needed to discuss ontologies, terminology
and standardized formats and to make data findable with rich me-
tadata. Such coordination could be possible to achieve via colla-
boration between funded projects, involvement of the Information
Platform for Chemical Monitoring (IPCHEM), and relevant
Commission services and agencies. Data should be stored in sys-
tematic, structured databases, with harmonised quality criteria. This
would facilitate making data more accessible and comparable and
help bridging the knowledge gaps. Likewise, international activities
such as the AOP initiative of the OECD or US-EPA data integration
efforts, e.g. Computational Toxicology Chemical Dashboard, could
provide advanced data and knowledge sharing.
2.2.3. Improving access to and transparency of data, including industry
data
It was highlighted by several workshop participants that missing or
inconsistent data on the toxicological properties of individual mixture
components are a serious obstacle to component-based mixture risk
assessment procedures. Information on the physico-chemical properties
of chemicals, expected uses and related exposures, as well as toxicity
data generated by industry for marketing approval or registration of
chemicals, should be made transparently available. Also, as stated in
the REACH Review (EC, 2018b), better quality of dossier information
provided to authorities by industry is needed. Mechanisms or incentives
to close such data and quality gaps, also across regulatory silos, are
either missing or considered insufficient. To this end, appropriate
enforcement and coordination measures must be implemented.
• Open access to data from industry studies
As a concrete step forward, it was proposed that industry and
business should be required to share data concerning exposure and
application of chemicals, including life-cycle assessment data. In
order to bring products to market, companies would have to test
new substances regarding exposure and application. Further, in-
formation on chemicals added to materials and consumer products
and goods should be made openly accessible. Large-scale users of
chemical products with known active ingredient(s), such as farmers,
would need to document their chemical product usage. These types
of data are valuable and could contribute to risk assessment of
chemicals and mixtures of chemicals. Therefore, legislation should
require industry and users to share this data with authorities and
make it publicly available. Also improved statistics on production,
sale and amounts of chemicals used or applied would be essential to
address data gaps or limitations in occurrence data.
2.3. Future research needs
2.3.1. Coordinated research initiatives and research strategy
It is important to establish precise objectives, legislative and sci-
entific, for the next ten years in the vast and complex field of chemical
mixtures. Clear objectives could pave the road towards more consistent
and complementary approaches and help avoid fragmentation, overlaps
and gaps in research and efforts. Focused, coordinated, inter- and
transdisciplinary research is needed that contributes to regulatory re-
levant issues but also towards wider understanding and new scientific
knowledge.
2.3.2. Perform targeted research into typical co-exposure patterns for
humans and wildlife
In many situations, only few mixture components may dominate the
overall risk. Further research on effect-based monitoring would help in
validating modelled exposures and prioritising chemical mixtures for
study. Risk reduction measures should consider such “drivers of toxi-
city”. However, the current knowledge on typical co-exposure patterns
is only rudimentary and monitoring is focused on relatively few che-
micals. Methods, such as untargeted screening, searching for emerging
substances that populations are burdened with should already be in-
cluded in approaches for monitoring. As we have limited ability to
monitor all chemicals, the development of reliable and robust models is
needed. These models have to be built on reliable and rich monitoring
data, such as HBM data. Thus, large-scale research initiatives as well as
relevant EU infrastructures for generating these data are required, and
they should include both co-exposure modelling and monitoring.
Further, there is a lack of information about the impact of chemicals on
different species and their interaction with environmental factors. Eco-
exposome research using large scale approaches, similar to some ideas
developed in HBM4EU project, would be needed to study the presence
of chemicals and their effects in the environment.
2.3.3. Research and guidance for assessing risks from combined and
sequential exposures
Progress has been made e.g. on dietary and non-dietary exposure
models, but very few studies have been done on how these modelled
exposures can be integrated in a single exposure estimate. Synergistic
interactions that result in significant excess toxicity over expected ad-
ditive effects are a long-standing concern of regulatory toxicology. The
knowledge about such effects is fragmentary and episodic. Systematic
investigations into the possible mechanisms and the possibilities to use
such knowledge for predictive mixture risk assessments deserve sup-
port. Further, currently available methodologies for mixture risk as-
sessment are largely confined to situations of simultaneous exposure to
multiple toxicants. Sequential exposure plays an important role in real
Environment International 134 (2020) 105267
4
world scenarios but it is an under-researched issue. Research should
focus on suitable concepts and method development for the predictive
assessment of resulting risks.
2.3.4. Strengthen the development of epidemiological approaches to mixture
risk assessment
While traditional epidemiology has addressed the health effects of
mixtures for decades through the use of exposure indicators, such in-
dicators do not always allow for the breakdown of the mixtures into
individual components. However, it can be difficult to disentangle the
real-world exposures inherent in epidemiology studies and identify the
drivers of observed health effects requiring remediation. Modern ad-
vances in epidemiological study designs, molecular epidemiology, ex-
posome studies, epigenetics, statistical modelling and existence of large
cohort studies enable more advanced use of epidemiology in mixture
risk assessment. The development of these advanced epidemiological
approaches to the assessment of mixture risks deserves further atten-
tion, as does the interaction with toxicological mixture risk research.
The observational nature of epidemiological studies allows a better
estimation of the possible magnitude of the mixture problem under
real-life conditions.
2.3.5. Develop further research based on the concepts of aggregate exposure
pathway (AEP) and adverse outcome pathway (AOP)
Chemicals interact with one another and can result in effects that
differ from the effects of the individual compounds. At this moment,
there is no systematic method of investigating interaction other than by
testing different combinations. The combination of AEP and AOP
(Teeguarden et al., 2016; Escher et al., 2017) suggests that the inter-
actions of chemicals can be organized into categories that may be more
amenable to systematic research. To assess the mixture problem, or-
ganised knowledge is essential. These two frameworks, one well es-
tablished, AOP, and the quite new AEP framework could help, in in-
tegrating mixture exposure information to link to health effect and
disease and inform modelling and experimental studies.
2.3.6. Integrated new approach methodologies (NAMs) for chemical testing
New approach methodologies (NAMs) addressing read-across and
alternative methods to animal testing as defined and discussed else-
where (ECHA, 2016) can provide quantitative mechanistic information
on single substances and mixture combinations. Intensified research on
NAMs will be essential to fill present knowledge gaps and overcome
current limitations. Given the vast amount of possible mixture effects,
such research should involve in silico approaches, advancing in vitro
methodologies as well as high throughput methods using tran-
scriptomics and apical end-points of toxicity testing. Such data will be
critical to provide quantitative dose-response relation information on
mixture effects for the scientific underpinning of mixture hazard iden-
tification and risk assessment. Integrated NAM testing will likely reduce
uncertainties on the health effects of mixture exposures. Translation to
epidemiological studies should involve refined biomarkers for adverse
target organ effects.
2.3.7. Transdisciplinary research on mixture risk governance
So far, little attention has been paid to the actual governance of
chemical mixtures. A wide range of regulations apply to chemicals, and
within the environmental, food safety and occupational arena, there is a
growing recognition of the importance of chemical mixtures. The
multitude and variability of exposure pathways makes the proper as-
sessment of mixture exposures and assessments of mixture impacts
complex and uncertain. Moreover, some of the exposures are in-
voluntary (environmental, occupational, food), while others are largely
self-determined (pharmaceuticals, alcohol, tobacco). Some have direct
benefits to the individual, e.g. pharmaceuticals, while some do not,
such as pesticides. This complexity leads to so-called ‘normative am-
biguity’, e.g. where experts hold different value-based positions with
regard to the acceptability of a risk, as opposed to ‘interpretative am-
biguity’ where experts differ in the interpretation of the scientific evi-
dence (Renn, 2008). This phenomenon also means that the complex,
uncertain and ambiguous subject of mixture risk management cannot
solely be executed through regulations, but it requires a wider in-
volvement of multiple stakeholders. To our knowledge, so far such a
transdisciplinary risk governance dialogue has not yet taken place.
Pertinent questions to address in a transdisciplinary research agenda,
for situations where the combined risks of mixtures are considered too
high, would include:
• What rules would govern the risk reduction and who has the re-
sponsibility to reduce mixture risks?• Should the main drivers of the risks be reduced, regardless of their
exposure route and of individual or societal benefits?• Should mixture risks in specific risk groups with the highest mixture
exposures and risks be addressed first (“peak shaving”), or should
the overall exposure distribution be reduced, to increase overall
public health gain?• How to ensure sufficient level of protection with regard to vulner-
able groups, such as pregnant women and children?• Should the individual and societal benefits play a role in optimizing
approaches for mixture risk reduction, e.g. is there room for risk/
benefit considerations?• Should all exposure routes be equally reduced or involuntary ex-
posures first?
Given the complexity of risk governance of mixtures and the un-
explored territory of risk reduction schemes, a ‘sandbox’ approach of
transdisciplinary research is proposed, to explore options and strategies
that lead to efficient and effective mixture risk reduction, with suffi-
cient societal support and minimum administrative burden.
2.3.8. Progress to mixture risk-benefit assessment, including sustainability
considerations
It is widely acknowledged that health and direct environmental risk
are not the only relevant indicators for decision makers. In addition,
more long-term sustainability factors and economic considerations are
relevant in the decision-making process. Multi-criteria decision making
(MCDM) models may be developed as part of governance research to
address the various aspects of the complex mixture issue and provide
further support for decision making.
3. Balancing uncertainties
Adding novel aspects to chemical risk assessment and surveillance is
often met with scepticism based on conservative assumptions about
uncertainty in other aspects of risk assessment and that additional
considerations will be overly restrictive. This argument needs to be
addressed in a comparative manner. Is there evidence for over-con-
servative assumptions regarding the various aspects of risk extrapola-
tion, and can we aggregate factors for uncertainty across different
sectors?
The complexity of mixture effects calls for a range of approaches to
address all facets of the problem. Realistic mixtures can be derived from
epidemiological and biomonitoring studies including untargeted
screening and can then be tested. Relevant mixtures for study can also
be identified through environmental monitoring or corresponding ex-
posome studies. However, this requires collaboration and communica-
tion between the human health and ecosystems fields and the
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development of modelling approaches to link mixtures measured in the
environment and human exposures.
The limitation of focusing exclusively on priority mixtures is that
they may not provide a sufficiently comprehensive basis that would
allow predictions to be made when new combinations are identified. In
this respect, complementary component-based approaches, based on
chemical groupings and mode of action, can be used to predict mixture
effects. While a diversity of research directions is required, tools for
regulatory decisions based on a tiered strategy should be rapidly im-
plemented to support sufficiently protective decisions. These could be
based on application of a MAF or use of default approaches such as dose
addition. Such measures could be revisited with the development of
additional knowledge.
Inescapably, there is a broad range of challenges to improve mixture
risk assessment and management. Challenges include better under-
standing of mixture exposure patterns in populations and ecosystems;
deeper insight into biology/mechanisms of adverse health and eco-
system effects; greater engagement with the social and policy/govern-
ance sciences; broader stakeholder dialogue with respect to possible
avenues for mixture risk governance and about acceptability of reg-
ulatory measures. To initiate clear progress across these multiple
challenges, extensive strategic transdisciplinary initiatives encom-
passing European and international collaborations are needed.
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